Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01783236 · ClinicalTrials.gov registry record · Phase 4

Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery

A Phase 4 study of Lung Tumor, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
Phase 4
Development phase
16
Enrollment target
1
Study location

NCT01783236 is a Phase 4 study of Lung Tumor that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01783236, a Phase 4 study of Lung Tumor, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
Phase 4
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

We will study the efficacy of FDA approved intravenous (IV) acetaminophen ("Ofirmev", © 2011 Cadence Pharmaceuticals, Inc.) in reducing opioid consumption after minimally invasive thoracic surgery in a double blind randomized trial. This drug has been shown in Europe to reduce the need for patient controlled analgesia and the total dose of opioids, which have serious side effects in thoracic surgery patients. We will compare the use of IV patient-controlled morphine (PCA) in two groups of subjects in treating postoperative pain. We will determine if IV acetaminophen reduces post-operative morphine requirements (primary end point). We will also assess subject pain scores and post-operative complications associated with pain management as secondary end points. Our hypothesis is that the study arm receiving intravenous acetaminophen will have lower total morphine consumptions compared to the placebo group.

Conditions Studied

Interventions

  • DRUG Saline Placebo
  • DRUG IV Acetaminophen

Study Locations (1)

New York

  • Weill Cornell Medical College - New York

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2013-06
Est. Completion 2015-07
Phase Phase 4

What the Registry Record Tells You About NCT01783236

The ClinicalTrials.gov registry entry for NCT01783236 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Tumor appearing as the primary indexed condition, and to 2 interventions - of which Saline Placebo is the first listed.

NCT01783236 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01783236 about?

NCT01783236 is a clinical study titled "Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery". We will study the efficacy of FDA approved intravenous (IV) acetaminophen ("Ofirmev", © 2011 Cadence Pharmaceuticals, Inc.) in reducing opioid consumption after minimally invasive thoracic surgery in a double blind randomized trial. This drug has been shown in Europe to reduce the need for patient c...

What is the current status of trial NCT01783236?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2013-06. Estimated completion is 2015-07.

What conditions does trial NCT01783236 study?

This clinical trial studies the following conditions: Lung Tumor.

What interventions are being tested in trial NCT01783236?

The interventions under investigation include: Saline Placebo (DRUG), IV Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT01783236?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01783236 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.